Lindsey Devisscher

4.7k total citations · 1 hit paper
99 papers, 2.2k citations indexed

About

Lindsey Devisscher is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Lindsey Devisscher has authored 99 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 25 papers in Surgery and 24 papers in Hepatology. Recurrent topics in Lindsey Devisscher's work include Liver Disease Diagnosis and Treatment (37 papers), Drug Transport and Resistance Mechanisms (13 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Lindsey Devisscher is often cited by papers focused on Liver Disease Diagnosis and Treatment (37 papers), Drug Transport and Resistance Mechanisms (13 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Lindsey Devisscher collaborates with scholars based in Belgium, United States and Germany. Lindsey Devisscher's co-authors include Hans Van Vlierberghe, Anja Geerts, Sander Lefere, Xavier Verhelst, Debby Laukens, Sarah Raevens, Mathieu Vinken, Christophe Van Steenkiste, Pieter Hindryckx and Martine De Vos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Lindsey Devisscher

94 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆

2020 209 citations Sander Lefere, Kevin De Muynck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lindsey Devisscher Belgium	28	857	587	496	468	320	99	2.2k
Francisco Javier Cubero Spain	32	1.3k 1.5×	937 1.6×	793 1.6×	404 0.9×	336 1.1×	90	2.9k
Matthias Froh United States	24	1.1k 1.2×	745 1.3×	649 1.3×	401 0.9×	284 0.9×	34	2.7k
Fernando Silva Ramalho Brazil	28	616 0.7×	628 1.1×	554 1.1×	585 1.3×	144 0.5×	109	2.4k
Toshiaki Nakano Japan	23	505 0.6×	566 1.0×	398 0.8×	401 0.9×	223 0.7×	132	2.2k
Yuko Akazawa Japan	25	804 0.9×	538 0.9×	261 0.5×	885 1.9×	250 0.8×	115	2.3k
Michele T. Pritchard United States	28	1.0k 1.2×	829 1.4×	504 1.0×	286 0.6×	147 0.5×	62	2.9k
Masataka Okuno Japan	28	489 0.6×	862 1.5×	457 0.9×	395 0.8×	339 1.1×	97	2.2k
Laura W. Schrum United States	29	1.3k 1.5×	1.2k 2.0×	1.1k 2.2×	450 1.0×	239 0.7×	67	3.0k
Yongping Chen China	28	1.1k 1.2×	1.1k 1.9×	955 1.9×	490 1.0×	145 0.5×	99	2.7k
Hideto Kawaratani Japan	27	1.3k 1.6×	756 1.3×	917 1.8×	472 1.0×	259 0.8×	136	2.6k

Countries citing papers authored by Lindsey Devisscher

Since Specialization

Citations

This map shows the geographic impact of Lindsey Devisscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsey Devisscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsey Devisscher more than expected).

Fields of papers citing papers by Lindsey Devisscher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsey Devisscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsey Devisscher. The network helps show where Lindsey Devisscher may publish in the future.

Co-authorship network of co-authors of Lindsey Devisscher

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsey Devisscher. A scholar is included among the top collaborators of Lindsey Devisscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsey Devisscher. Lindsey Devisscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Casteleyn, Christophe, Sara Neyt, Benedicte Descamps, et al.. (2025). The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Biomedicine & Pharmacotherapy. 183. 117826–117826. 2 indexed citations

Gansemans, Yannick, Joél Smet, Xavier Verhelst, et al.. (2025). Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD. JHEP Reports. 7(6). 101404–101404. 1 indexed citations

Paepe, Kim De, Hans Van Vlierberghe, Sarah Raevens, et al.. (2025). The double-edged sword of metabolic and bariatric surgery: extending the biliary limb can trigger bacterial translocation, sepsis, and liver inflammation – an experimental study. International Journal of Surgery. 111(7). 4239–4251. 2 indexed citations

Sanz-Serrano, Julen, et al.. (2024). Effects of per- and polyfluoroalkyl substances on the liver: Human-relevant mechanisms of toxicity. The Science of The Total Environment. 954. 176717–176717. 13 indexed citations

Devisscher, Lindsey, et al.. (2024). Lumen‐apposing metal stents for anastomosis creation throughout the gastrointestinal tract: A large single‐center experience. SHILAP Revista de lepidopterología. 5(1). e419–e419. 1 indexed citations

Lefere, Sander, et al.. (2024). Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease. SHILAP Revista de lepidopterología. 2(1). 13–13. 7 indexed citations

Lefere, Sander, Dorien Clarisse, Lisa L. Koorneef, et al.. (2024). PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression. Metabolism. 164. 156128–156128. 4 indexed citations

Raevens, Sarah, Christophe Van Steenkiste, Isabelle Colle, et al.. (2024). External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort. JHEP Reports. 6(9). 101149–101149. 1 indexed citations

Pauwels, N., Anja Geerts, Sarah Raevens, et al.. (2024). Glycomics as prognostic biomarkers of hepatocellular carcinoma: A systematic review. Oncology Letters. 29(1). 24–24. 2 indexed citations

10.

Vanderborght, Bart, Kevin De Muynck, Eva Gijbels, et al.. (2023). Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte‐derived cells does not alter the induction or progression of hepatocellular carcinoma. International Journal of Cancer. 152(12). 2615–2628. 6 indexed citations

11.

Muynck, Kevin De, Bart Vanderborght, Federico F. De Ponti, et al.. (2023). Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis. American Journal Of Pathology. 193(4). 366–379. 9 indexed citations

12.

Gijbels, Eva, et al.. (2021). Biomarkers of Cholestasis. Biomarkers in Medicine. 15(6). 437–454. 20 indexed citations

13.

Hoecke, Lien Van, Sander Lefere, Anja Geerts, et al.. (2021). The neurogliovascular unit in hepatic encephalopathy. JHEP Reports. 3(5). 100352–100352. 37 indexed citations

14.

Lefere, Sander, Frederique Van de Velde, Sarah Raevens, et al.. (2018). Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis. Ghent University Academic Bibliography (Ghent University). 2 indexed citations

15.

Holvoet, Tom, Sarah Devriese, Karolien Castermans, et al.. (2017). Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor. Gastroenterology. 153(4). 1054–1067. 110 indexed citations

16.

Bossche, Lien Van den, Sarah Devriese, Sophie Van Welden, et al.. (2017). Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn's disease-like ileitis. Laboratory Investigation. 97(5). 519–529. 39 indexed citations

17.

Neyt, Sara, Ken Kersemans, Jeroen Verhoeven, et al.. (2017). Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice. PLoS ONE. 12(3). e0173529–e0173529. 15 indexed citations

18.

Devisscher, Lindsey, Stijn Schauvliege, Jeroen Dewulf, & Frank Gasthuys. (2010). Romifidine as a constant rate infusion in isoflurane anaesthetized horses: a clinical study. Veterinary Anaesthesia and Analgesia. 37(5). 425–433. 31 indexed citations

19.

Martens, Ann, et al.. (2009). Distal limb cast sores in horses: risk factors and early detection using thermography. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

20.

Torfs, Sara, Cathérine Delesalle, Jeroen Dewulf, Lindsey Devisscher, & Piet Deprez. (2009). Risk Factors for Equine Postoperative Ileus and Effectiveness of Prophylactic Lidocaine. Journal of Veterinary Internal Medicine. 23(3). 606–611. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact